Keith Ward7 days agoKuria to present at the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting 2025- Kuria to present positive preclinical proof-of-concept data for lead NRF2 activator for both cornea and retina disease Kuria...